SynthesisEuropean journal of haematology2007

Efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparison.

H Miles Prince et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.